Professional Supply 99% Raw Steroid Anabolic Hormone Powders Semi-finished injection oils ,Oral oils,SARMS and Peptides.
Payment & Shipping Terms:
pharmaceutical grade powder
High Purity Anabolic SARM Steroids / Cardarine Fat Loss GW-501516 Pharmaceutical Grade
GW-501516 Product description :
GW 501516 is extremely popular and is extremely effective. The effects it has on increased
endurance and fat loss have been staggering. The recommended dosage for GW is 10-20 mg
and for 8 weeks length. GW has shown to have drastic effects and little to no side effects. It is a
favorite amongst many users and offers several great benefits.
GW 501516 can be ran in 8 week cycles, but as with any other steroid or supplement, it should
be cycled properly to avoid any possible side effects and the keep it as effective as possible.
We have the following SARMs manufactured,
Ostarine, MK-2866, Enobosarm
Enobosarm (Ostarine, MK-2866, GTx-024) - affects both muscle and bone, intended mainly for
osteoporosis but also general treatment for andropause and reversing muscle sarcopenia in the
elderly and for cachexia in cancer patients.
Pharmacological profile similar to that of enobosarm, Ostarine, MK-2866
MK-677, Ibutamoren, secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly
Partial agonist, intended mainly for treatment of benign prostatic hypertrophy
all of our products will be highly discreet packaged and sent. if any interests, please contact me freely.
Recommend SARMs Series We Supply:
|MK-2866, Ostarine, Enobosarm||841205-47-8||medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy.|
|MK-677, Ibutamoren||15972-10-0||A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly|
|LGD-4033, Ligandrol||1165910-22-4||pharmacological profile similar to that of enobosarm, Ostarine,MK-2866|
|GW501516, Cardarine||317318-70-0||For obesity, diabetes, dyslipidemia and cardiovascular disease|
|Andarine(S4)||401900-40-0||partial agonist, intended mainly for treatment of benign prostatic hypertrophy|
|SR9009||1379686-30-2||under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice|
|RAD140||1182367-47-0||New generation for gaining mass and cutting edges|
|YK11||431579-34-9||YK11: a SARM and myostatin inhibitor in one|
|AICAR||2627-69-2||acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown|